![Epitope masking may limit antibody boosting to malaria vaccines - Kurtovic - 2021 - Immunology & Cell Biology - Wiley Online Library Epitope masking may limit antibody boosting to malaria vaccines - Kurtovic - 2021 - Immunology & Cell Biology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/85073b15-ace6-4c9b-9e71-1c9e5ddac022/imcb12415-toc-0001-m.jpg)
Epitope masking may limit antibody boosting to malaria vaccines - Kurtovic - 2021 - Immunology & Cell Biology - Wiley Online Library
![Structure and design of Probody therapeutics. (A) A Probody therapeutic... | Download Scientific Diagram Structure and design of Probody therapeutics. (A) A Probody therapeutic... | Download Scientific Diagram](https://www.researchgate.net/publication/283575362/figure/fig1/AS:312446981033984@1451504573248/Structure-and-design-of-Probody-therapeutics-A-A-Probody-therapeutic-is-a-monoclonal.png)
Structure and design of Probody therapeutics. (A) A Probody therapeutic... | Download Scientific Diagram
![Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody | Nature Communications Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-020-16838-w/MediaObjects/41467_2020_16838_Fig1_HTML.png)
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody | Nature Communications
![Strategies to enhance monoclonal antibody uptake and distribution in solid tumors | Cancer Biology & Medicine Strategies to enhance monoclonal antibody uptake and distribution in solid tumors | Cancer Biology & Medicine](https://www.cancerbiomed.org/content/cbm/18/3/649/F1.large.jpg)
Strategies to enhance monoclonal antibody uptake and distribution in solid tumors | Cancer Biology & Medicine
![Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies. - Abstract - Europe PMC Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3546534/bin/nihms341274f1.jpg)
Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies. - Abstract - Europe PMC
![The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control | ACS Central Science The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control | ACS Central Science](https://pubs.acs.org/cms/10.1021/acscentsci.0c01448/asset/images/large/oc0c01448_0002.jpeg)
The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control | ACS Central Science
![Frontiers | Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity Frontiers | Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity](https://www.frontiersin.org/files/Articles/715719/fimmu-12-715719-HTML/image_m/fimmu-12-715719-g001.jpg)
Frontiers | Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity
![Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-020-00652-z/MediaObjects/12929_2020_652_Fig7_HTML.png)
Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text
![PDF] A Search for the Masked Mechanism Behind IgG-Mediated Suppression of Antibody Responses | Semantic Scholar PDF] A Search for the Masked Mechanism Behind IgG-Mediated Suppression of Antibody Responses | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/98eb93918f8aac0c168c70ecee9779bb580b54ee/42-Figure3-1.png)
PDF] A Search for the Masked Mechanism Behind IgG-Mediated Suppression of Antibody Responses | Semantic Scholar
![Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies - ScienceDirect Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1074761318303066-fx1.jpg)
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies - ScienceDirect
![Tunable modulation of antibody‐antigen interaction by protease cleavage of protein M - Kim - 2019 - Biotechnology and Bioengineering - Wiley Online Library Tunable modulation of antibody‐antigen interaction by protease cleavage of protein M - Kim - 2019 - Biotechnology and Bioengineering - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/574d6491-a996-43ab-a7fd-feb829772f56/bit27111-fig-0001-m.jpg)
Tunable modulation of antibody‐antigen interaction by protease cleavage of protein M - Kim - 2019 - Biotechnology and Bioengineering - Wiley Online Library
![Frontiers | Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity Frontiers | Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity](https://www.frontiersin.org/files/Articles/715719/fimmu-12-715719-HTML/image_m/fimmu-12-715719-g002.jpg)
Frontiers | Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity
![The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals | Journal of Nuclear Medicine The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/62/4/438/F7.large.jpg)
The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals | Journal of Nuclear Medicine
![Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-020-00652-z/MediaObjects/12929_2020_652_Fig6_HTML.png)
Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text
![The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by 89Zr-immuno-PET in xenograft bearing mice The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by 89Zr-immuno-PET in xenograft bearing mice](https://www.thno.org/v10/p5815/toc.jpg)
The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by 89Zr-immuno-PET in xenograft bearing mice
![Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-020-00652-z/MediaObjects/12929_2020_652_Fig5_HTML.png)
Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text
![Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-020-00652-z/MediaObjects/12929_2020_652_Fig3_HTML.png)